Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001171843-16-011868

Director sold 18,062 shares at an average $7.93 ($143,156)

From the SEC's structured data for this filing

Trades in this filing

HOLLER FRANK A · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2016-08-16 Sale : show line 1 in the form −6,863 $8.25 $56,620 169,006 D
2016-08-17 Sale : show line 2 in the form −1,600 $7.89 $12,624 167,406 D
2016-08-18 Sale : show line 3 in the form −9,599 $7.70 $73,912 157,807 D
Open-market sales · 18,062 sh · avg $7.93 · $143,156
Loading xslF345X03/f4_holler081816.xml…